Literature DB >> 28634175

Inter-relations between 3-hydroxypropionate and propionate metabolism in rat liver: relevance to disorders of propionyl-CoA metabolism.

Kirkland A Wilson1, Yong Han2, Miaoqi Zhang1, Jeremy P Hess2, Kimberly A Chapman3,4, Gary W Cline5, Gregory P Tochtrop2, Henri Brunengraber6, Guo-Fang Zhang7.   

Abstract

Propionate, 3-hydroxypropionate (3HP), methylcitrate, related compounds, and ammonium accumulate in body fluids of patients with disorders of propionyl-CoA metabolism, such as propionic acidemia. Although liver transplantation alleviates hyperammonemia, high concentrations of propionate, 3HP, and methylcitrate persist in body fluids. We hypothesized that conserved metabolic perturbations occurring in transplanted patients result from the simultaneous presence of propionate and 3HP in body fluids. We investigated the inter-relations of propionate and 3HP metabolism in perfused livers from normal rats using metabolomic and stable isotopic technologies. In the presence of propionate, 3HP, or both, we observed the following metabolic perturbations. First, the citric acid cycle (CAC) is overloaded but does not provide sufficient reducing equivalents to the respiratory chain to maintain the homeostasis of adenine nucleotides. Second, there is major CoA trapping in the propionyl-CoA pathway and a tripling of liver total CoA within 1 h. Third, liver proteolysis is stimulated. Fourth, propionate inhibits the conversion of 3HP to acetyl-CoA and its oxidation in the CAC. Fifth, some propionate and some 3HP are converted to nephrotoxic maleate by different processes. Our data have implications for the clinical management of propionic acidemia. They also emphasize the perturbations of the liver intermediary metabolism induced by supraphysiological, i.e., millimolar, concentrations of labeled propionate used to trace the intermediary metabolism, in particular, inhibition of CAC flux and major decreases in the [ATP]/[ADP] and [ATP]/[AMP] ratios.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  3-hydroxypropionate; liver; metabolomic and stable isotopic analysis; propionate; propionic acidemia

Mesh:

Substances:

Year:  2017        PMID: 28634175      PMCID: PMC5668600          DOI: 10.1152/ajpendo.00105.2017

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  88 in total

1.  Nonhomogeneous labeling of liver mitochondrial acetyl-CoA.

Authors:  C Des Rosiers; F David; M Garneau; H Brunengraber
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

2.  A case of methylmalonic and propionic acidemia due to methulmalonyl-CoA carbonylmutase apoenzyme deficiency.

Authors:  H van den Berg; M T Boelkens; F A Hommes
Journal:  Acta Paediatr Scand       Date:  1976-01

3.  Isolation and identification of methylcitrate, a major metabolic product of propionate in patients with propionic acidemia.

Authors:  T Ando; K Rasmussen; J M Wright; W L Nyhan
Journal:  J Biol Chem       Date:  1972-04-10       Impact factor: 5.157

4.  Fatty acid, 3-beta-hydroxysterol, and ketone synthesis in the perfused rat liver. Effects of (--)-hydroxycitrate and oleate.

Authors:  H Brunengraber; M Boutry; J M Lowenstein
Journal:  Eur J Biochem       Date:  1978-01-16

5.  Metabolism of malonic semialdehyde in man.

Authors:  R D Scholem; G K Brown
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

6.  Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs.

Authors:  Guo-Fang Zhang; Rajan S Kombu; Takhar Kasumov; Yong Han; Sushabhan Sadhukhan; Jianye Zhang; Lawrence M Sayre; Dale Ray; K Michael Gibson; Vernon A Anderson; Gregory P Tochtrop; Henri Brunengraber
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

7.  Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle: II. Heterogeneity of metabolite labeling pattern.

Authors:  Lili Yang; Takhar Kasumov; Rajan S Kombu; Shu-Han Zhu; Andrea V Cendrowski; France David; Vernon E Anderson; Joanne K Kelleher; Henri Brunengraber
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

8.  Cardiomyopathies in propionic aciduria are reversible after liver transplantation.

Authors:  Stéphane Romano; Vassili Valayannopoulos; Guy Touati; Jean-Pierre Jais; Daniel Rabier; Yves de Keyzer; Damien Bonnet; Pascale de Lonlay
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

9.  A Carbonyl Capture Approach for Profiling Oxidized Metabolites in Cell Extracts.

Authors:  Stephanie J Mattingly; Tao Xu; Michael H Nantz; Richard M Higashi; Teresa W-M Fan
Journal:  Metabolomics       Date:  2012-01-19       Impact factor: 4.290

10.  Augmenting ureagenesis in patients with partial carbamyl phosphate synthetase 1 deficiency with N-carbamyl-L-glutamate.

Authors:  Nicholas Ah Mew; Robert McCarter; Yevgeny Daikhin; Uta Lichter-Konecki; Ilana Nissim; Marc Yudkoff; Mendel Tuchman
Journal:  J Pediatr       Date:  2014-05-29       Impact factor: 4.406

View more
  13 in total

1.  Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.

Authors:  M Sol Collado; Allison J Armstrong; Matthew Olson; Stephen A Hoang; Nathan Day; Marshall Summar; Kimberly A Chapman; John Reardon; Robert A Figler; Brian R Wamhoff
Journal:  Mol Genet Metab       Date:  2020-05-11       Impact factor: 4.797

2.  Disruption of mitochondrial functions involving mitochondrial permeability transition pore opening caused by maleic acid in rat kidney.

Authors:  Ana Cristina Roginski; Ângela Beatris Zemniaçak; Rafael Aguiar Marschner; Simone Magagnin Wajner; Rafael Teixeira Ribeiro; Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  J Bioenerg Biomembr       Date:  2022-07-29       Impact factor: 3.853

3.  Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia.

Authors:  Chitra Subramanian; Matthew W Frank; Rajendra Tangallapally; Mi-Kyung Yun; Anne Edwards; Stephen W White; Richard E Lee; Charles O Rock; Suzanne Jackowski
Journal:  Sci Transl Med       Date:  2021-09-15       Impact factor: 17.956

Review 4.  Flux analysis of inborn errors of metabolism.

Authors:  D-J Reijngoud
Journal:  J Inherit Metab Dis       Date:  2018-01-09       Impact factor: 4.982

Review 5.  Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.

Authors:  Edward S Chambers; Tom Preston; Gary Frost; Douglas J Morrison
Journal:  Curr Nutr Rep       Date:  2018-12

Review 6.  Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions.

Authors:  Kanmani Suganya; Byung-Soo Koo
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

7.  The presence of 3-hydroxypropionate and 1,3-propanediol suggests an alternative path for conversion of glycerol to Acetyl-CoA.

Authors:  Eunsook S Jin; Min H Lee; Craig R Malloy
Journal:  Metabol Open       Date:  2021-02-26

8.  Decrease of disease-related metabolites upon fasting in a hemizygous knock-in mouse model (Mut-ko/ki) of methylmalonic aciduria.

Authors:  Marie Lucienne; Déborah Mathis; Nathan Perkins; Ralph Fingerhut; Matthias R Baumgartner; D Sean Froese
Journal:  JIMD Rep       Date:  2020-11-08

9.  Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine.

Authors:  Yingxue Wang; Bridgette A Christopher; Kirkland A Wilson; Deborah Muoio; Robert W McGarrah; Henri Brunengraber; Guo-Fang Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-17       Impact factor: 4.310

10.  Increased protein propionylation contributes to mitochondrial dysfunction in liver cells and fibroblasts, but not in myotubes.

Authors:  Bart Lagerwaard; Olga Pougovkina; Anna F Bekebrede; Heleen Te Brinke; Ronald J A Wanders; Arie G Nieuwenhuizen; Jaap Keijer; Vincent C J de Boer
Journal:  J Inherit Metab Dis       Date:  2020-08-17       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.